Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution
- PMID: 24704627
- DOI: 10.1016/j.atherosclerosis.2014.03.014
Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution
Abstract
Background: Junctional adhesion molecule (JAM-) A is a transmembrane protein expressed in many cell types and maintains junctional integrity in endothelial cells. Upon inflammatory stimulation, JAM-A relocates to the apical surface and might thereby facilitate the recruitment of leukocytes.
Objective: Although inflammatory JAM-A redistribution is an established process, further effort is required to understand its exact role in the transmigration of mononuclear cells, particularly under atherogenic conditions.
Methods: By the use of RNA interference and genetic deletion, the role of JAM-A in the transmigration of T cells and monocytes through aortic endothelial cells was investigated. JAM-A-localization and subsequent mononuclear cell rolling, adhesion and transmigration were explored during endothelial inflammation, induced by oxidized LDL or cytokines.
Results: RNA interference or genetic deletion of JAM-A in aortic endothelial cells resulted in a decreased transmigration of mononuclear cells. Treatment of the endothelial cells with oxLDL resulted in an increase of both permeability and apical JAM-A presentation, as shown by bead adhesion and confocal microscopy experiments. Redistribution of JAM-A resulted in an increased leukocyte adhesion and transmigration, which could be inhibited with antibodies against JAM-A or by lovastatin-treatment, but not with the peroxisome proliferator activated receptor gamma-agonist pioglitazone.
Conclusions: This study demonstrates that redistribution of JAM-A in endothelial cells after stimulation with pro-atherogenic oxidized lipoproteins results in increased transmigration of mononuclear cells. This inflammatory dispersal of JAM-A could be counteracted with statins, revealing a novel aspect of their mechanism of action.
Keywords: Atherosclerosis; Endothelial cells; F11R; JAM-1; Junctional adhesion molecule; Statin; Transmigration.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
JAM-A: Adhesion Receptor and Signaling Regulator in Atherosclerosis.Curr Atheroscler Rep. 2025 Jul 29;27(1):75. doi: 10.1007/s11883-025-01322-x. Curr Atheroscler Rep. 2025. PMID: 40728654 Free PMC article. Review.
-
The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment.FASEB J. 2005 Dec;19(14):2078-80. doi: 10.1096/fj.05-4196fje. Epub 2005 Sep 29. FASEB J. 2005. PMID: 16195363
-
Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis.Circulation. 2014 Jan 7;129(1):66-76. doi: 10.1161/CIRCULATIONAHA.113.004149. Epub 2013 Sep 24. Circulation. 2014. PMID: 24065611
-
Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.Circ Res. 2015 Feb 13;116(4):587-99. doi: 10.1161/CIRCRESAHA.116.304035. Epub 2014 Dec 3. Circ Res. 2015. PMID: 25472975
-
F11R/JAM-A: why do platelets express a molecule which is also present in tight junctions?Platelets. 2023 Dec;34(1):2214618. doi: 10.1080/09537104.2023.2214618. Platelets. 2023. PMID: 37246517 Review.
Cited by
-
Mesenchymal stem-cell-derived exosomal miR-145 inhibits atherosclerosis by targeting JAM-A.Mol Ther Nucleic Acids. 2020 Nov 4;23:119-131. doi: 10.1016/j.omtn.2020.10.037. eCollection 2021 Mar 5. Mol Ther Nucleic Acids. 2020. PMID: 33335797 Free PMC article.
-
Endothelial Cell Inflammatory Reactions Are Altered in the Presence of E-Cigarette Extracts of Variable Nicotine.Cell Mol Bioeng. 2016 Aug 24;10(1):124-133. doi: 10.1007/s12195-016-0465-4. eCollection 2017 Feb. Cell Mol Bioeng. 2016. PMID: 31719854 Free PMC article.
-
Where the Action Is-Leukocyte Recruitment in Atherosclerosis.Front Cardiovasc Med. 2022 Jan 11;8:813984. doi: 10.3389/fcvm.2021.813984. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35087886 Free PMC article. Review.
-
JAM-A: Adhesion Receptor and Signaling Regulator in Atherosclerosis.Curr Atheroscler Rep. 2025 Jul 29;27(1):75. doi: 10.1007/s11883-025-01322-x. Curr Atheroscler Rep. 2025. PMID: 40728654 Free PMC article. Review.
-
Junctional Adhesion Molecules: Potential Proteins in Atherosclerosis.Front Cardiovasc Med. 2022 Jul 7;9:888818. doi: 10.3389/fcvm.2022.888818. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35872908 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical